Company Performance: Hanmi Pharmaceutical's financial health, including revenue, profitability, and debt levels, significantly impacts its stock price. Strong earnings reports typically drive the price up, while losses can lead to a decline. Industry Trends: The overall performance and outlook of the pharmaceutical industry influence investor sentiment towards Hanmi. Positive industry growth forecasts can attract investors, boosting the stock. Regulatory Environment: Changes in drug regulations, pricing policies, and approval processes by regulatory bodies like the Ministry of Food and Drug Safety (MFDS) can affect Hanmi's operations and profitability, influencing its stock price. Competition: The intensity of competition from other pharmaceutical companies, both domestic and international, affects Hanmi's market share and pricing power. New drug launches by competitors can pressure Hanmi's stock. Macroeconomic Factors: Economic indicators like interest rates, inflation, and currency exchange rates can influence investor confidence and the availability of capital, impacting the overall stock market and Hanmi's stock. Global Health Events: Pandemics or outbreaks of infectious diseases can affect demand for certain drugs and vaccines, potentially benefiting or harming Hanmi's stock price depending on its product portfolio. Research & Development: The success of Hanmi's R&D efforts in developing new drugs and therapies is crucial. Positive clinical trial results can drive the stock up, while failures can lead to a decline. Investor Sentiment: Market psychology, news headlines, and overall investor confidence can play a significant role in short-term price fluctuations, even if the underlying fundamentals remain unchanged.